Tetrabenazine



Tetrabenazine





(tet ra ben’ ah zeen)

Xenazine

PREGNANCY CATEGORY C


Drug Classes

Anti-chorea drug

Monoamine depletor



Therapeutic Actions

Inhibits monoamine transport systems, resulting in a decreased uptake of the monoamines dopamine, serotonin, norepinephrine, and histamine into synaptic vesicles and a depletion of monoamine stores; exact mechanism of action of effects on chorea are not understood.


Indications



  • Treatment of chorea associated with Huntington disease



Available Forms

Tablets—12.5, 25 mg


Dosages

Adults

12.5 mg/day PO in the morning; after 1 week, increase to 12.5 mg PO bid; may be slowly titrated as needed to a maximum dose of 100 mg/day in divided doses.

Pediatric patients

Safety and efficacy not established.


Pharmacokinetics















Route Onset Peak
Oral Slow 2 hr

Metabolism: Hepatic; T1/2: 4–8 hr, then 2–4 hr (active metabolite)

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 21, 2016 | Posted by in NURSING | Comments Off on Tetrabenazine

Full access? Get Clinical Tree

Get Clinical Tree app for offline access